BioPharm News

Nov 05, 2018
By BioPharm International Editors
Fujifilm Diosynth Biotechnologies and the Centre for Process Innovation (CPI) are collaborating to complete the technology transfer of the expression and purification of model monoclonal antibodies (mAbs) as part of AMECRYS, a research project funded by the European Commission.
Nov 02, 2018
By BioPharm International Editors
The company received FDA approval for Hyrimoz (adalimumab-adaz), its biosimilar referencing AbbVie’s blockbuster Humira (adalimumab).
Nov 02, 2018
By BioPharm International Editors
Cytek Biosciences’ Northern Lights series of advanced flow cytometry systems brings reagent and application flexibility to more labs while enhancing performance.
Nov 01, 2018
By BioPharm International Editors
New data highlights ability of the SQZ cell therapy platform to preserve cellular functions.
Nov 01, 2018
By BioPharm International Editors
This new partnership provides access to Distributed Bio’s antibody discovery platforms.
Nov 01, 2018
By BioPharm International Editors
Thermo Fisher Scientific has entered into a collaboration with Symphogen to deliver validated, platform workflows for simplified characterisation and quality monitoring of complex therapeutic proteins.
Oct 31, 2018
By BioPharm International Editors
A statement from FDA Commissioner Scott Gottlieb and Deputy Commissioner Anna Abram detailed FDA’s new plan to advance plant and animal biotechnology innovation.
Oct 31, 2018
By BioPharm International Editors
A project funded by BioProNET will investigate optimization for bioprocessing of gene therapy vectors using hydrodynamic fluid flow fields.
Oct 30, 2018
By BioPharm International Editors
The companies announced the European launch of Imraldi (adalimumab), a biosimilar referencing AbbVie’s blockbuster Humira (adalimumab).
Oct 30, 2018
By BioPharm International Editors
Mylan announced the launch of its biosimilar to AbbVie’s Humira across major European markets.
native1_300x100
lorem ipsum